Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BIENVENU J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 85 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nicolas, L; Monneret, G; Debard, AL; Blesius, A; Gutowski, MC; Salles, G; Bienvenu, J
      Human gamma delta T cells express a higher TCR/CD3 complex density than alpha beta T cells

      CLINICAL IMMUNOLOGY
    2. Muser, J; Bienvenu, J; Blanckaert, N; Brandslund, I; Delattre, J; Soffiati, G; Swaminathan, R; Maggini, S; Mastall, H
      Inter-laboratory evaluation of the COBAS INTEGRA (R) 400 analytical system

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    3. Cousin, F; Philips, K; Favier, B; Bienvenu, J; Nicolas, JF
      Drug-induced urticaria

      EUROPEAN JOURNAL OF DERMATOLOGY
    4. Baseggio, L; Charlot, C; Picollet, J; Bienvenu, J; Salles, G
      High circulating tumor necrosis factor levels correlate with increased levels of soluble CD14 in patients with non-Hodgkin's lymphoma

      HAEMATOLOGICA
    5. Baseggio, L; Bienvenu, J; Charlot, C; Picollet, J; Felman, P; Coiffier, B; Salles, G
      Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from non-Hodgkin's lymphoma patients

      EXPERIMENTAL HEMATOLOGY
    6. Whicher, J; Bienvenu, J; Monneret, G
      Procalcitonin as an acute phase marker

      ANNALS OF CLINICAL BIOCHEMISTRY
    7. Bienvenu, J; Monneret, G; Fabien, N; Revillard, JP
      The clinical usefulness of the measurement of cytokines

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    8. Monneret, G; Pachot, A; Laroche, B; Picollet, J; Bienvenu, J
      Procalcitonin and calcitonin gene-related peptide decrease LPS-induced TNFproduction by human circulating blood cells

      CYTOKINE
    9. Voog, E; Bienvenu, J; Warzocha, K; Moullet, I; Dumontet, C; Thieblemont, C; Monneret, G; Gutowski, MC; Coiffier, B; Salles, G
      Factors that predict chemotherapy-induced myelosuppression in lymphoma patients: Role of the tumor necrosis factor ligand-receptor system

      JOURNAL OF CLINICAL ONCOLOGY
    10. Warzocha, K; Ribeiro, P; Renard, N; Bienvenu, J; Charlot, C; Coiffier, B; Salles, G
      Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    11. Glehen, O; Peyrat, P; Beaujard, A; Caillot, JL; Francois, Y; Gueugniaud, PY; Garbit, F; Bienvenu, J; Vignal, J; Gilly, FN
      Abdominal cancer with peritoneal carcinomatosis treated by peritonectomy procedure and intraperitoneal chemohyperthermia

      EXPERIMENTAL ONCOLOGY
    12. Beaujard, AC; Glehen, O; Caillot, JL; Francois, Y; Bienvenu, J; Panteix, G; Garbit, F; Grandclement, E; Vignal, J; Gilly, FN
      Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis

      CANCER
    13. Dode, C; Papo, T; Fieschi, C; Pecheux, C; Dion, E; Picard, F; Godeau, P; Bienvenu, J; Piette, JC; Delpech, M; Grateau, G
      A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family

      ARTHRITIS AND RHEUMATISM
    14. Conrozier, T; Carlier, MC; Mathieu, P; Colson, F; Debard, AL; Richard, S; Favret, H; Bienvenu, J; Vignon, E
      Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study

      ANNALS OF THE RHEUMATIC DISEASES
    15. Monneret, G; Benoit, Y; Gutowski, MC; Bienvenu, J
      Detection of basophil activation by flow cytometry in patients with allergy to muscle-relaxant drugs

      ANESTHESIOLOGY
    16. Berthier, F; Lambert, C; Genin, C; Bienvenu, J
      Evaluation of an automated immunoassay method for cytokine measurement using the Immulite (R) immunoassay system

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    17. Bayer, PM; Bauerfeind, S; Bienvenu, J; Fabien, N; Frei, PC; Gilburd, B; Heide, KG; Hoier-Madsen, M; Meroni, PL; Monier, JC; Monneret, G; Panzeri, P; Shoenfeld, Y; Spertini, F; Wiik, A
      Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay

      JOURNAL OF AUTOIMMUNITY
    18. Fabien, N; Moreira, A; Lavergne, JP; Desbos, A; Surgey, P; de Olivera, CA; Gonzalo, P; Venot, A; Bienvenu, J; Perrier, H; Reboud, JP; Monier, JC
      Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins

      JOURNAL OF AUTOIMMUNITY
    19. Dumontet, C; Drai, J; Bienvenu, J; Berard, EN; Thieblemont, C; Bouafia, F; Bayle, F; Moullet, I; Salles, G; Coiffier, B
      Profiles and prognostic values of LDH isoenzymes in patients lymphoma

      LEUKEMIA
    20. Monneret, G; Laroche, B; Bienvenu, J
      Procalcitonin is not produced by circulating blood cells

      INFECTION
    21. Gilly, FN; Beaujard, A; Glehen, O; Grandclement, E; Caillot, JL; Francois, Y; Sadeghi-Looyeh, B; Gueugniaud, PY; Garbit, F; Benoit, M; Bienvenu, J; Vignal, J
      Peritonectomy combined with intraperitoneal chemohyperthermia in abdominalcancer with peritoneal carcinomatosis: Phase I-II study

      ANTICANCER RESEARCH
    22. Sayag-Beaujard, AC; Francois, Y; Glehen, O; Sadeghi-Looyeh, B; Bienvenu, J; Panteix, G; Garbit, F; Grandclement, E; Vignal, J; Gilly, FN
      Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis

      ANTICANCER RESEARCH
    23. Gilly, FN; Beaujard, A; Bienvenu, J; Lenoir, VT; Glehen, O; Thouvenot, D; Malcus, C; Favrot, M; Dumontet, C; Lomhard-Bohas, C; Garbit, F; Gueugniaud, PY; Vignal, J; Aymard, M; Moulin, FT; Roos, M; Pavirani, A; Courtney, M
      Gene therapy with AdV-IL-2 in unresectable digestive cancer: Phase I-II study, intermediate report

      HEPATO-GASTROENTEROLOGY
    24. Durieu, I; Amsellem, C; Paulin, C; Chambe, MT; Bienvenu, J; Ballon, G; Pacheco, Y
      Fas and Fas ligand expression in cystic fibrosis airway epithelium

      THORAX
    25. Sibille, M; Deigat, N; Durieu, I; Guillaumont, M; Morel, D; Bienvenu, J; Massignon, D; Durand, DV
      Laboratory data in healthy volunteers: reference values, reference changes, screening and laboratory adverse event limits in phase I clinical trials

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    26. Martin-Denavit, T; Monneret, G; Labaune, JM; Isaac, C; Bienvenu, F; Putet, G; Bienvenu, J
      Usefulness of procalcitonin in neonates at risk for infection

      CLINICAL CHEMISTRY
    27. Monneret, G; Gutowski, MC; Bienvenu, J
      Detection of allergen-induced basophil activation by expression of CD63 antigen using a tricolour flow cytometric method

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    28. MONNERET G; DOCHE C; DURAND DV; LEPAPE A; BIENVENU J
      PROCALCITONIN AS A SPECIFIC MARKER OF BACTERIAL-INFECTION IN ADULTS

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    29. Monneret, G; Labaune, JM; Isaac, C; Bienvenu, F; Putet, G; Bienvenu, J
      Increased serum procalcitonin levels are not specific to sepsis in neonates

      CLINICAL INFECTIOUS DISEASES
    30. BONNEFOY M; AYZAC L; INGENBLEEK Y; KOSTKA T; BOISSON RC; BIENVENU J
      USEFULNESS OF THE PROGNOSTIC INFLAMMATORY AND NUTRITIONAL INDEX (PINI) IN HOSPITALIZED ELDERLY PATIENTS

      International journal for vitamin and nutrition research
    31. BEAUNE G; BIENVENU F; PONDARRE C; MONNERET G; BIENVENU J; SOUILLET G
      SERUM PROCALCITONIN RISE IS ONLY SLIGHT IN 2 CASES OF DISSEMINATED ASPERGILLOSIS

      Infection
    32. Haddad, A; Bienvenu, J; Miossec, P
      Increased production of a Th2 cytokine profile by activated whole blood cells from rheumatoid arthritis patients

      JOURNAL OF CLINICAL IMMUNOLOGY
    33. LAPILLONNE A; BASSON E; MONNERET G; BIENVENU J; SALLE BL
      LACK OF SPECIFICITY OF PROCALCITONIN FOR SEPSIS DIAGNOSIS IN PREMATURE-INFANTS

      Lancet
    34. NESTADT G; BIENVENU J; CAI GJ; SAMUELS J; EATON WW
      INCIDENCE OF OBSESSIVE-COMPULSIVE DISORDER IN ADULTS

      The Journal of nervous and mental disease
    35. PEREVERGE D; BIENVENU J; FLOURIE B; DESCOS L
      SERUM LEVELS OF INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) AND SOLUBLE TUMOR-NECROSIS-FACTOR ALPHA-RECEPTOR (STNF-ALPHA-R) IN SEVERE ATTACKS OF ULCERATIVE-COLITIS

      Gastroenterology
    36. BIENVENU J; GRAZIANI MS; ARPIN F; BERNON H; BLESSUM C; MARCHETTI C; RIGHETTI G; SOMENZINI M; VERGA G; AGUZZI F
      MULTICENTER EVALUATION OF THE PARAGON CZE(TM)-2000 CAPILLARY-ZONE-ELECTROPHORESIS SYSTEM FOR SERUM-PROTEIN ELECTROPHORESIS AND MONOCLONAL COMPONENT TYPING

      Clinical chemistry
    37. MUSER I; BIENVENU J; BLANCKAERT N; BRANDSLUND I; DELATTRE J; SWAMINATHAN R
      INTERNATIONAL MULTICENTER EVALUATION OF THE COBAS(R) INTEGRA-400 CLINICAL-CHEMISTRY ANALYZER

      Clinical chemistry
    38. WARZOCHA K; RIBEIRO P; BIENVENU J; ROY P; CHARLOT C; COIFFIER B; SALLES G
      INHERITED SUSCEPTIBILITY FOR INCREASE TNF PRODUCTION IMPAIRS LYMPHOMAPATIENTS OUTCOME

      British Journal of Haematology
    39. WARZOCHA K; BIENVENU J; RIBEIRO P; MOULLET I; DUMONTET C; NEIDHARDTBERARD EM; COIFFIER B; SALLES G
      PLASMA-LEVELS OF TUMOR-NECROSIS-FACTOR AND ITS SOLUBLE RECEPTORS CORRELATE WITH CLINICAL-FEATURES AND OUTCOME OF HODGKINS-DISEASE PATIENTS

      British Journal of Cancer
    40. WARZOCHA K; RIBEIRO P; BIENVENU J; ROY P; CHARLOT C; RIGAL D; COIFFIER B; SALLES G
      GENETIC POLYMORPHISMS IN THE TUMOR-NECROSIS-FACTOR LOCUS INFLUENCE NON-HODGKINS-LYMPHOMA OUTCOME

      Blood
    41. BELLON G; MICHELCALEMARD L; THOUVENOT D; JAGNEAUX V; POITEVIN F; MALCUS C; ACCART N; LAYANI MP; AYMARD M; BERNON H; BIENVENU J; COURTNEY M; DORING G; GILLY B; GILLY R; LAMY D; LEVREY H; MOREL Y; PAULIN C; PERRAUD F; RODILLON L; SENE C; SO S; TOURAINEMOULIN F; SCHATZ C; PAVIRANI A
      AEROSOL ADMINISTRATION OF A RECOMBINANT ADENOVIRUS EXPRESSING CFTR TOCYSTIC-FIBROSIS PATIENTS - A PHASE-I CLINICAL-TRIAL

      Human gene therapy
    42. GILLY FN; SAYAGBEAUJARD AC; BIENVENU J; AYMARD M; TOURAINEMOULIN F; FAVROT M; TRILLETLENOIR V; PAVIRANI A; COURTNEY M; FRANCOIS Y; GLEHEN O; BANSSILLON V; VIGNAL J; ROSS M
      GENE-THERAPY WITH ADV-IL2 (TG-1021) IN UNRESECTABLE DIGESTIVE ADENOCARCINOMA - PHASE I-II STUDY, FIRST INCLUSIONS

      Cancer gene therapy
    43. MONNERET G; LABAUNE JM; ISAAC C; BIENVENU F; PUTET G; BIENVENU J
      PROCALCITONIN AND C-REACTIVE PROTEIN-LEVELS IN NEONATAL INFECTIONS

      Acta paediatrica
    44. WARZOCHA K; SALLES G; BIENVENU J; BASTION Y; DUMONTET C; RENARD N; NEIDHARDTBERARD EM; COIFFIER B
      TUMOR-NECROSIS-FACTOR LIGAND-RECEPTOR SYSTEM CAN PREDICT TREATMENT OUTCOME IN LYMPHOMA PATIENTS

      Journal of clinical oncology
    45. WARZOCHA K; BIENVENU J; CHARLOT C; RENARD N; RIBEIRO P; COIFFIER B; SALLES G
      POLYMORPHIC STRUCTURE OF THE TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN-ALPHA LOCI IN NON-HODGKINS-LYMPHOMA PATIENTS

      Experimental hematology
    46. ROBINET E; STAMM C; NICOLAS JF; FAURE M; MERCATELLO A; CORONEL B; WIJDENES J; BIENVENU J; REVILLARD JP; CLAUDY A
      CD4 MONOCLONAL-ANTIBODY ADMINISTRATION IN ATOPIC-DERMATITIS

      Journal of the American Academy of Dermatology
    47. BENAHMED M; HEYMANN D; PILET P; BIENVENU J; DACULSI G
      LPS INCREASES BIOMATERIAL DEGRADATION BY HUMAN MONOCYTES IN-VITRO

      Journal of biomedical materials research
    48. FRANCOIS Y; GRANDCLEMENT E; SAYAGBEAUJARD AC; GLEHEN O; SADEGHILOOYEH B; BIENVENU J; PEYRAT PP; GARBIT F; VIGNAL J; GILLY FN
      INTRAPERITONEAL CHEMOHYPERTHERMIA WITH MI TOMYCIN-C FOR GASTRIC-CANCER WITH PERITONEAL CARCINOSIS

      Journal de chirurgie
    49. WARZOCHA K; RIBEIRO P; BIENVENU J; ROY P; CHARLOT C; COIFFIER B; SALLES G
      GENETIC POLYMORPHISMS IN THE TUMOR-NECROSIS-FACTOR REGION INFLUENCE NON-HODGKINS-LYMPHOMA OUTCOME

      Blood
    50. WARZOCHA K; RENARD N; CHARLOT C; BIENVENU J; COIFFIER B; SALLES G
      IDENTIFICATION OF 2 LYMPHOTOXIN-BETA ISOFORMS EXPRESSED IN HUMAN LYMPHOID-CELL LINES AND NON-HODGKINS-LYMPHOMAS

      Biochemical and biophysical research communications
    51. CHAMBRIER C; BOULETREAU P; BIENVENU J
      UNTITLED

      Annals of surgery
    52. DATI F; SCHUMANN G; THOMAS L; AGUZZI F; BAUDNER S; BIENVENU J; BLAABJERG O; BLIRUPJENSEN S; CARLSTROM A; HYLTOFTPETERSEN P; JOHNSON AM; MILFORDWARD A; RITCHIE RF; SVENDSEN PJ; WHICHER J
      CONSENSUS OF A GROUP OF PROFESSIONAL-SOCIETIES AND DIAGNOSTIC-COMPANIES ON GUIDELINES FOR INTERIM REFERENCE RANGES FOR 14 PROTEINS IN SERUMBASED ON THE STANDARDIZATION AGAINST THE IFCC BCR/CAP REFERENCE MATERIAL (CRM-470)/

      European journal of clinical chemistry and clinical biochemistry
    53. DOCHE C; THOME M; DIMET I; BIENVENU J
      EVALUATION OF THE FULLY AUTOMATED COBAS CORE ENZYME-IMMUNOASSAY FOR THE QUANTITATION OF ANTIBODIES AGAINST HEPATITIS-B VIRUS SURFACE-ANTIGEN

      European journal of clinical chemistry and clinical biochemistry
    54. PEILLON D; DUBOST J; ROCHE C; BIENVENU J; BRETON P; CARRY PY; FREIDEL M; BANSSILLON V
      EFFECT OF CORTICOSTEROIDS AND HEMODILUTIO N ON POSTOPERATIVE INFLAMMATION AFTER MAXILLOFACIAL SURGERY

      Annales francaises d'anesthesie et de reanimation
    55. WHICHER JT; BAUDNER S; BIENVENU J; BLIRUPJENSEN S; CARLSTROM A; DATI F; JOHNSON MA; RITCHIE RF; SVENDSEN PJ; WARD AM
      NEW INITIATIVES IN THE STANDARDIZATION OF PROTEIN MEASUREMENTS

      Pure and applied chemistry
    56. HAMZAOUI N; VAILLANT E; BIENVENU J; DESCOS L
      PROGNOSTIC VALUE OF INTERLEUKIN-6 SOLUBLE RECEPTOR (IL6SR) AND INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL1RA) PLASMA-CONCENTRATIONS IN CROHNS-DISEASE (CD)

      Gastroenterology
    57. LIEVENS M; BIENVENU J; BUITRAGO JMG; CARLIER MC; DOLCI A; FERRERO C; FUHRMANN P; LULEY C; MUHLBAYER D; PEISKER K; SIEGEL R; POPPE W; DOMKE I
      MULTICENTER EVALUATION OF 5 NEW TURBIDIMETRIC ASSAYS FOR ALPHA-1-ACIDGLYCOPROTEIN, ALPHA-1-ANTITRYPSIN, CERULOPLASMIN, HAPTOGLOBIN AND PREALBUMIN

      Clinical chemistry
    58. LAMMERS M; BIENVENU J; MONNERET G; DELARREA LB; GAONA N; SCHUMANN G; STEVENS WJ; VANCAMPENHOUT C
      EVALUATION OF AN IMPROVED IMMUNONEPHELOMETRIC ASSAY FOR C-REACTIVE PROTEIN

      Clinical chemistry
    59. SALLES G; BIENVENU J; BASTION Y; BARBIER Y; DOCHE C; WARZOCHA K; GUTOWSKI MC; RIEUX C; COIFFIER B
      ELEVATED CIRCULATING LEVELS OF TNF-ALPHA AND ITS P55 SOLUBLE RECEPTORARE ASSOCIATED WITH AN ADVERSE PROGNOSIS IN LYMPHOMA PATIENTS

      British Journal of Haematology
    60. WARZOCHA K; RENARD N; CHARLOT C; BIENVENU J; COIFFIER B; SALLES G
      LYMPHOTOXIN-ALPHA (LT-ALPHA) AND LYMPHOTOXIN-BETA (LT-BETA) GENES EXPRESSION IN TRANSFORMED-CELL LINES AND NON-HODGKINS-LYMPHOMAS - PRESENCE OF AN ALTERNATIVELY SPLICED FORM OF LT-BETA

      Blood
    61. WARZOCHA K; RENARD N; CHARLOT C; BIENVENU J; BASTION Y; NEIDHARTBERARD EM; DUMONTET C; COIFFIER B; SALLES G
      THE TUMOR-NECROSIS-FACTOR, LYMPHOTOXIN AND FAS LIGAND-RECEPTOR SYSTEMGENES EXPRESSION IN NON-HODGKINS-LYMPHOMAS

      Blood
    62. CHAMBRIER C; CHASSARD D; BIENVENU J; SAUDIN F; PATUREL B; GARRIGUE C; BARBIER Y; BOULETREAU A
      CYTOKINE AND HORMONAL CHANGES AFTER CHOLECYSTECTOMY - EFFECT OF IBUPROFEN PRETREATMENT

      Annals of surgery
    63. WARZOCHA K; BIENVENU J; COIFFIER B; SALLES G
      MECHANISMS OF ACTION OF THE TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN LIGAND-RECEPTOR SYSTEM

      European cytokine network
    64. PEILLON D; DUBOST J; BIENVENU J; CARRY PY; ROCHE C; BRETON P; FREIDEL M; BANSSILLON V
      ACUTE NORMOVOLEMIC HEMODILUTION DOES NOT REDUCE THE INFLAMMATORY PROCESS-INDUCED BY FACIAL SURGERY

      Canadian journal of anaesthesia
    65. TEBIB JG; LETROUBLON MC; NOEL E; BIENVENU J; BOUVIER M
      SIL-2R LEVELS IN RHEUMATOID-ARTHRITIS - POOR CORRELATION WITH CLINICAL ACTIVITY IS DUE IN PART TO DISEASE DURATION

      British journal of rheumatology
    66. GILLY FN; SAYAG AC; CARRY PY; BRACHET A; FRANCOIS Y; PANTEIX FG; GRIOT JB; BIENVENU J; VIGNAL J; BANSSILLON V; BRAILLON G
      INTRAPERITONEAL CHEMOHYPERTHERMIA (WITH MITOMYCIN-C) FOR DIGESTIVE CANCERS WITH PERITONEAL CARCINOMATOSIS

      Eksperimental'naa onkologia
    67. BIENVENU J; DOCHE C; GUTOWSKI MC; LENOBLE M; LEPAPE T; PERDRIX JP
      PRODUCTION OF PROINFLAMMATORY CYTOKINES AND CYTOKINES INVOLVED IN THETH1 TH2 BALANCE IS MODULATED BY PENTOXIFYLLINE/

      Journal of cardiovascular pharmacology
    68. FOSSAT C; FABRE D; ALIMI Y; BIENVENU J; AILLAUD MF; LENOBLE M; JUHANVAGUE I; JUHAN C
      LEUKOCYTE ACTIVATION STUDY DURING OCCLUSIVE ARTERIAL-DISEASE OF THE LOWER-LIMB - EFFECT OF PENTOXIFYLLINE INFUSION

      Journal of cardiovascular pharmacology
    69. HAMZAOUI N; BIENVENU J; DESCOS L
      INTERLEUKIN-6 (IL-6), INTERLEUKIN-6 SOLUBLE RECEPTOR (IL-6SR), AND INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL1RA) PLASMA-CONCENTRATIONS IN CROHNS-DISEASE

      Gastroenterology
    70. BASTION Y; CAMPOS L; ROUBI N; BIENVENU J; FELMAN P; DUMONTET C; COIFFIER B
      IL-3 INCREASES MARROW AND PERIPHERAL ERYTHROID PRECURSORS IN CHRONIC PURE RED-CELL APLASIA PRESENTING IN CHILDHOOD

      British Journal of Haematology
    71. WARZOCHA K; SALLES G; BIENVENU J; BASTION Y; COIFFIER B
      HIGH TUMOR-NECROSIS-FACTOR-ALPHA, ITS SOLUBLE RECEPTORS P55 AND P75 BUT NOT LYMPHOTOXIN-ALPHA PLASMA-LEVELS ARE RELATED TO ADVERSE PROGNOSTIC FACTORS AND POOR OUTCOME IN LYMPHOMA PATIENTS

      Blood
    72. BONNEFOY M; COULON L; BIENVENU J; BOISSON RC; RYS L
      IMPLICATION OF CYTOKINES IN THE AGGRAVATION OF MALNUTRITION AND HYPERCATABOLISM IN ELDERLY PATIENTS WITH SEVERE PRESSURE SORES

      Age and ageing
    73. DUMONTET C; REBBAA A; BIENVENU J; PORTOUKALIAN J
      INHIBITION OF IMMUNE CELL-PROLIFERATION AND CYTOKINE PRODUCTION BY LIPOPROTEIN-BOUND GANGLIOSIDES

      Cancer immunology and immunotherapy
    74. MASSIGNON D; LEPAPE A; BIENVENU J; BARBIER Y; BOILEAU C; COEUR P
      COAGULATION FIBRINOLYSIS BALANCE IN SEPTIC SHOCK RELATED TO CYTOKINESAND CLINICAL STATE/

      Haemostasis
    75. GILLY FN; CARRY PY; SAYAG AC; BRACHET A; PANTEIX G; SALLE B; BIENVENU J; BURGARD G; GUIBERT B; BANSSILLON V; BRAILLON G
      REGIONAL CHEMOTHERAPY (WITH MITOMYCIN-C) AND INTRAOPERATIVE HYPERTHERMIA FOR DIGESTIVE CANCERS WITH PERITONEAL CARCINOMATOSIS

      Hepato-gastroenterology
    76. WHICHER JT; FITCHIE RF; JOHNSON AM; BAUDNER S; BIENVENU J; BLIRUPJENSEN S; CARLSTROM A; DATI F; WARD AM; SVENDSEN PJ
      NEW INTERNATIONAL REFERENCE PREPARATION FOR PROTEINS IN HUMAN SERUM (RPPHS)

      Clinical chemistry
    77. BIENVENU J; COULON L; DOCHE C; GUTOWSKI MC; GRAU GE
      ANALYTICAL PERFORMANCES OF COMMERCIAL ELISA-KITS FOR IL-2, IL-6 AND TNF-ALPHA - A WHO STUDY

      European cytokine network
    78. ALEXANDRE P; AMIRAL J; BIENVENU J; BORG JY; BRIDEY F; CAHAN L; COMBE S; DELAHOUSSE B; DREYFUS M; GAUTHIER C; JUHANVAGUE I; LANDAUER D; MUSITELLI JJ; POUZOL P; RAISKY F; REYNAUD J; SIE P; SITBON O; TREZIAC MC
      MARKERS OF HEMOSTATIC SYSTEM ACTIVATION IN ACUTE DEEP VENOUS THROMBOSIS-EVOLUTION DURING THE FIRST DAYS OF HEPARIN TREATMENT

      Thrombosis and haemostasis
    79. POZZETTO B; ODELIN MF; BIENVENU J; DEFAYOLLE M; AYMARD M
      IS THERE A RELATIONSHIP BETWEEN MALNUTRITION, INFLAMMATION, AND POST-VACCINAL ANTIBODY-RESPONSE TO INFLUENZA-VIRUSES IN THE ELDERLY

      Journal of medical virology
    80. PANTEIX G; CHERPIN L; GILLY FN; SAYAG A; BRACHET A; BALTASSAT P; GUILLAUMONT M; CUICHARD J; CARRY PY; SALLE B; BIENVENU J; BRAILLON G
      STUDY OF THE PHARMACOKINETICS OF MITOMYCIN-C IN HUMANS DURING INTRAPERITONEAL CHEMOHYPERTHERMIA WITH SPECIAL MENTION OF THE CONCENTRATION IN LOCAL TISSUES

      Oncology
    81. COULON L; GUTOWSKI MC; BARBIER M; GILLY FN; SAYAG A; BIENVENU J; BARBIER Y; PANTEIX G; CARRY PY; BRAILLON G
      CYTOKINE PRODUCTION DURING INTRAPERITONEAL CHEMOHYPERTHERMIA

      Oncology
    82. SALLES G; BIENVENU J; BASTION Y; BARBIER M; DOCHE C; DUMONTET C; BARBIER Y; FELMAN P; COIFFIER B
      ELEVATED CIRCULATING ALPHA-TNF AND SOLUBLE TNF-RECEPTOR LEVELS ARE ASSOCIATED WITH ADVERSE PROGNOSTIC FACTORS AND POOR OUTCOME IN LYMPHOMA PATIENTS

      Blood
    83. GILLY FN; CARRY PY; SAYAG AC; PANTEIX GG; BIENVENU J; BRACHET A; SALLE B; BRAILLON G
      GASTRIC-CANCER WITH PERITONEAL CARCINOMATOSIS - DOES HYPERTHERMIA CONSTITUTE A NEW THERAPEUTIC APPROACH

      Annales de chirurgie
    84. GILLY FN; CARRY PY; BRACHET A; SAYAG AC; PANTEIX G; SALLE B; BIENVENU J; BANSSILLON V; BURGARD G; MANCHON M; ROCHETTE A; BRAILLON G
      TREATMENT OF MALIGNANT PERITONEAL EFFUSION IN DIGESTIVE AND OVARIAN-CANCER

      Medical oncology and tumor pharmacotherapy
    85. BIENVENU J; COULON L; BARBIER Y; BARBIER M; DOCHE C; LEPAPE A; GUENOUNOU M
      STUDY OF PENTOXIFYLLINE INDUCED MODULATION OF TNF-ALPHA AND INTERLEUKIN-6 SECRETION IN HEALTHY AND SEPTIC PATIENTS BY THE USE OF AN EX-VIVOMODEL ON WHOLE-BLOOD

      Nouvelle revue francaise d'hematologie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 14/08/20 alle ore 15:57:26